Special Issue "Nutraceuticals in Cardiovascular and Metabolic Diseases"
Deadline for manuscript submissions: 31 July 2021.
Interests: cardiovascular diseases; autophagy; nutraceuticals; stroke; mitochondrial dysfunction
2. Department of Vascular Physiopathology, IRCCS Neuromed, 86077 Pozzilli, Italy
Interests: cardiovascular diseases; blood pressure; nitric oxide signaling; oxidative stress
Special Issues and Collections in MDPI journals
Cardiovascular and metabolic diseases, including heart failure, atherosclerosis, and metabolic syndrome, are serious health issues that affect the general population worldwide. Lifestyle improvements and improved nutrition appear to be efficacious strategies for reducing the effects of cardio-metabolic diseases and their associated risk factors. Nutraceuticals exert promising health-promoting effects, both for prevention of disease and to support current therapies, as observed in preclinical and clinical studies. The reduction of oxidative stress is one of the target mechanisms common to many nutraceuticals, but compelling evidence has also shown the ability of these molecules to modulate additional signalling, such as cell clearing systems, mitochondrial metabolism, and nutrient sensing pathways, which are usually dysregulated in cardiovascular and metabolic diseases. However, many aspects concerning the use of nutraceuticals in human diseases should be further clarified. Plasma bioavailability and tissue distribution after intake are not well characterized for many nutraceuticals, and the molecular mechanisms underlying their beneficial effects are not fully understood. The identification of new nutraceuticals in natural sources is also encouraged.
This Special Issue will focus on the role of nutraceuticals in cardiovascular and metabolic diseases. We invite authors to submit original articles covering studies performed as basic research, applied research, pre-clinical models of diseases, and review articles.
Dr. Maurizio Forte
Dr. Albino Carrizzo
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cardiovascular diseases
- metabolic diseases
- oxidative stress
- bioactive compounds
- metabolic syndrome
- heart failure
- vascular dysfunction